Retatrutide

Retatrutide 40mg

What is Retatrutide?

Retatrutide 40mg is a synthetic multi-receptor peptide that researchers study for its interaction with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. As a result, it has become an important research compound in studies focused on metabolic regulation, energy balance, and receptor signalling pathways. Additionally, its unique triple-agonist design distinguishes it from many other peptide compounds currently used in laboratory research. Because Retatrutide interacts with multiple metabolic receptors simultaneously, researchers use it in experimental models that investigate complex biochemical pathways. Therefore, Retatrutide continues to attract significant interest within peptide research and receptor pharmacology studies.

Retatrutide Chemical Information

• CAS Number: 2381089-83-2
• PubChem CID: 171934787
• Molecular Formula: C221H342N46O68
• Molecular Weight: ~4731.33 g/mol

Retatrutide Specifications and Formulation

This Retatrutide product is supplied as a high-purity, lyophilised peptide. Furthermore, the freeze-dried format enhances peptide stability during storage and transportation. In addition, researchers can reconstitute the peptide according to specific laboratory requirements. Each batch undergoes rigorous quality control procedures to ensure consistency and reliability. Therefore, researchers can expect reproducible quality across production lots. Purity is verified through HPLC analysis, with results reaching ≥99%.

Product Specifications

• Content: Retatrutide lyophilised peptide
• Form: Freeze-dried powder
• Purity: ≥99% HPLC-verified
• COA: Certificate of Analysis provided for every batch
• Storage: –20°C in temperature-controlled facility until dispatch
• Origin: UK-stocked for rapid delivery

 

Applications of Retatrutide in Research

Researchers utilise Retatrutide in laboratory studies involving metabolic signalling pathways and receptor pharmacology. Moreover, its activity across GLP-1, GIP, and glucagon receptors makes it particularly valuable in studies investigating complex hormonal interactions. Typical research areas include:

• Metabolic pathway research
• GLP-1 receptor studies
• GIP receptor signalling investigations
• Glucagon receptor research
• Energy balance and expenditure models
• Receptor pharmacology studies
• Peptide-receptor interaction analysis
• Endocrine signalling research

As a result, Retatrutide has become an increasingly important tool in advanced peptide research programmes.

Storage and Stability of Retatrutide

Proper storage conditions help preserve the stability and integrity of Retatrutide. However, inappropriate handling may affect peptide quality over time.

• Store at –20°C in a controlled environment
• Keep protected from heat, light, and moisture
• Avoid repeated freeze-thaw cycles
• Store reconstituted solutions according to laboratory protocols

Additionally, all batches are stored under controlled conditions before dispatch to maintain product quality.

Intended Use of Retatrutide

Retatrutide is intended strictly for laboratory research purposes only. It is not approved for human or veterinary use. Furthermore, it must not be used for diagnostic, therapeutic, or consumption purposes. Researchers are responsible for ensuring compliance with all applicable local laws and regulations regarding the handling and use of Retatrutide.

Why Researchers Use Retatrutide

Retatrutide is valued in research environments due to its highly specific receptor activity and well-characterised biochemical profile. Additionally, the peptide offers consistent performance under controlled laboratory conditions, making it suitable for advanced metabolic and receptor signalling studies. Therefore, Retatrutide remains a widely sought-after compound within peptide and pharmacological research.

SEO Keywords for Retatrutide

Retatrutide 4omg, Retatrutide peptide 4omg, Retatrutide research peptide 40mg, CAS 2381089-83-2, Retatrutide lyophilised peptide, Retatrutide laboratory use, triple agonist peptide, GLP-1 GIP glucagon receptor peptide, Retatrutide research compound, metabolic research peptide, Retatrutide UK, Retatrutide HPLC tested, Retatrutide peptide research, Retatrutide 40mg, Retatrutide third-party tested, Janoshik verified Retatrutide.